• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国成年人中衰老、肥胖和胰岛素抵抗与新发糖尿病关联的数据驱动聚类分析:一项多中心回顾性队列研究

Data-driven cluster analysis on the association of aging, obesity and insulin resistance with new-onset diabetes in Chinese adults: a multicenter retrospective cohort study.

作者信息

Wang Yazhi, Zhang Mingkang, Wang Peng

机构信息

The Second School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.

The School of Pharmacy, Lanzhou University, Lanzhou, Gansu, China.

出版信息

Front Med (Lausanne). 2025 Jul 30;12:1640017. doi: 10.3389/fmed.2025.1640017. eCollection 2025.

DOI:10.3389/fmed.2025.1640017
PMID:40809436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12343622/
Abstract

BACKGROUND

Type 2 diabetes mellitus (T2DM) is an endocrine and metabolic disorder that can lead to multi-organ damage and dysfunction, imposing significant financial burden on national healthcare systems. Currently, the early identification of high-risk individuals and the prevention of T2DM remain major challenges for clinicians. This study aimed to use easily obtainable clinical indicators to perform cluster analysis on healthy individuals, in order to accurately identify high-risk population requiring early intervention.

METHODS

This study was a multicenter retrospective cohort study with a median follow-up period of 3 years. A total of 12,607 Chinese adult individuals without diabetes at baseline were included. The K-means clustering algorithm was applied to five standardized indicators: age, body mass index (BMI), fasting blood glucose (FBG), triglycerides (TG), and HDL-C (high-density lipoprotein cholesterol). After clustering, multivariate Cox proportional hazards regression analysis was used to evaluate and compare the risk of diabetes incidence among different clusters.

RESULTS

The study population comprising 12,607 subjects was clustered into four distinct groups: Cluster 1 (metabolic health cluster), Cluster 2 (low HDL-C cluster), Cluster 3 (old age and mild metabolic disorder cluster), and Cluster 4 (severe obesity and insulin resistance cluster). The proportional distributions of each cluster were 37.95, 29.99, 24.95, and 7.11%, respectively. The clinical characteristics and diabetes incidence risks varied significantly among the four clusters. Cluster 4 exhibited the highest diabetes incidence rate, followed by Cluster 3, Cluster 2, and Cluster 1. In all models adjusted for covariates, the diabetes incidence rates in Cluster 3 and Cluster 4 were significantly higher than those in Cluster 1 and Cluster 2. However, no significant difference was observed between Cluster 3 and Cluster 4.

CONCLUSION

Cluster-based analyses can effectively identify individuals at high risk of diabetes in the normal population. These high-risk groups (clusters 3 and 4) are often associated with aging, obesity, and insulin resistance (IR), necessitating early and targeted interventions.

摘要

背景

2型糖尿病(T2DM)是一种内分泌和代谢紊乱疾病,可导致多器官损伤和功能障碍,给国家医疗保健系统带来巨大经济负担。目前,早期识别高危个体和预防T2DM仍然是临床医生面临的主要挑战。本研究旨在利用易于获得的临床指标对健康个体进行聚类分析,以准确识别需要早期干预的高危人群。

方法

本研究是一项多中心回顾性队列研究,中位随访期为3年。共纳入12607名基线时无糖尿病的中国成年个体。将K均值聚类算法应用于五个标准化指标:年龄、体重指数(BMI)、空腹血糖(FBG)、甘油三酯(TG)和高密度脂蛋白胆固醇(HDL-C)。聚类后,采用多变量Cox比例风险回归分析评估和比较不同聚类中糖尿病发病风险。

结果

由12607名受试者组成的研究人群被分为四个不同的组:第1组(代谢健康组)、第2组(低HDL-C组)、第3组(老年和轻度代谢紊乱组)和第4组(严重肥胖和胰岛素抵抗组)。每组的比例分布分别为37.95%、29.99%、24.95%和7.11%。四个聚类的临床特征和糖尿病发病风险差异显著。第4组糖尿病发病率最高,其次是第3组、第2组和第1组。在所有经协变量调整的模型中,第3组和第4组的糖尿病发病率显著高于第1组和第2组。然而,第3组和第4组之间未观察到显著差异。

结论

基于聚类的分析可以有效地识别正常人群中糖尿病高危个体。这些高危组(第3组和第4组)通常与衰老、肥胖和胰岛素抵抗(IR)相关,需要早期和有针对性的干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/180003e83a31/fmed-12-1640017-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/9e92a8095da9/fmed-12-1640017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/ee09372126c1/fmed-12-1640017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/d5b853da36f9/fmed-12-1640017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/180003e83a31/fmed-12-1640017-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/9e92a8095da9/fmed-12-1640017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/ee09372126c1/fmed-12-1640017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/d5b853da36f9/fmed-12-1640017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2313/12343622/180003e83a31/fmed-12-1640017-g004.jpg

相似文献

1
Data-driven cluster analysis on the association of aging, obesity and insulin resistance with new-onset diabetes in Chinese adults: a multicenter retrospective cohort study.中国成年人中衰老、肥胖和胰岛素抵抗与新发糖尿病关联的数据驱动聚类分析:一项多中心回顾性队列研究
Front Med (Lausanne). 2025 Jul 30;12:1640017. doi: 10.3389/fmed.2025.1640017. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
4
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.
5
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.糖尿病合并妊娠:内分泌学会与欧洲内分泌学会联合临床实践指南
J Clin Endocrinol Metab. 2025 Jul 13. doi: 10.1210/clinem/dgaf288.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
8
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
9
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Association between insulin resistance indices and outcomes in patients with heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者胰岛素抵抗指数与预后的关系
Cardiovasc Diabetol. 2025 Jan 22;24(1):32. doi: 10.1186/s12933-025-02595-x.
2
Data-driven cluster analysis of lipids, inflammation, and aging in relation to new-onset type 2 diabetes mellitus.与新发2型糖尿病相关的脂质、炎症和衰老的数据驱动聚类分析。
Endocrine. 2025 Apr;88(1):151-161. doi: 10.1007/s12020-024-04154-y. Epub 2025 Jan 2.
3
Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases.
甘油三酯葡萄糖(TyG)指数:一种用于不同疾病诊断和治疗的有前景的生物标志物。
Eur J Intern Med. 2025 Jan;131:3-14. doi: 10.1016/j.ejim.2024.08.026. Epub 2024 Oct 29.
4
Diabetes, Prediabetes, and Brain Aging: The Role of Healthy Lifestyle.糖尿病、糖尿病前期与大脑衰老:健康生活方式的作用。
Diabetes Care. 2024 Oct 1;47(10):1794-1802. doi: 10.2337/dc24-0860.
5
Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus.体成分纵向变化与超重/肥胖和 2 型糖尿病患者肾脏结局风险的关系。
Diabetes Obes Metab. 2024 Sep;26(9):3597-3605. doi: 10.1111/dom.15699. Epub 2024 Jun 10.
6
Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.超加工食品暴露与健康不良结局:流行病学荟萃分析的伞式综述。
BMJ. 2024 Feb 28;384:e077310. doi: 10.1136/bmj-2023-077310.
7
Harnessing the power of proteomics in precision diabetes medicine.利用蛋白质组学在精准糖尿病医学中的力量。
Diabetologia. 2024 May;67(5):783-797. doi: 10.1007/s00125-024-06097-5. Epub 2024 Feb 12.
8
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.非高密度脂蛋白胆固醇在血脂异常中的作用:最新文献综述及展望。
Atherosclerosis. 2023 Oct;383:117312. doi: 10.1016/j.atherosclerosis.2023.117312. Epub 2023 Sep 30.
9
Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial.在一项大型随机试验中,每年对地中海饮食的依从情况与糖尿病的发病率。
Cardiovasc Diabetol. 2023 Sep 29;22(1):262. doi: 10.1186/s12933-023-01994-2.
10
Association of obesity profiles and metabolic health status with liver injury among US adult population in NHANES 1999-2016.1999-2016 年美国 NHANES 成人人群中肥胖表型和代谢健康状况与肝损伤的关系。
Sci Rep. 2023 Sep 25;13(1):15958. doi: 10.1038/s41598-023-43028-7.